Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2011 to YTD 2017 12
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deal Details 16
Asset Purchase 16
Menarini Raunaq Pharma Plans To Acquire Pharma Brands In India For US$80 Million 16
Invida Acquires Dermatology And Primary Care Product Portfolios From Shalaks Pharma For US$20 Million 17
Partnerships 19
Melinta Therapeutics Enters into Agreement with Menarini 19
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 20
Menarini Asia-Pacific Enters into Agreement with Merck 21
Menarini Forms Joint Venture with BiosYnth 22
Moberg Extends Distribution Agreement with Menarini for Emtrix 23
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 24
Moberg Pharma Extends Distribution Agreement With Menarini 25
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 26
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 27
Menarini Enters Into Agreement With Oxford BioTherapeutics To Develop Antibody-Based Anticancer Drugs 28
Teijin Pharma Extends Co-Marketing Agreement With Menarini For TMX-67 30
Moberg Derma Enters Into Co-Marketing Agreement With Menarini For Emtrix 31
Sinclair Pharma Extends Co-Marketing Agreement With Invida 32
Teijin Pharma Enters Into Co-Marketing Agreement With Menarini Group For TMX-67 33
Invida Group Enters Into Agreement With F. Hoffmann-La Roche 34
Licensing Agreements 36
Berlin-Chemie Enters into Licensing Agreement with Selvita 36
Berlin-Chemie Enters into Licensing Agreement with Chugai Pharma 37
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 38
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 39
Menarini Enters into Licensing and Development Agreement with 4SC for Resminostat 40
Vivus Enters Into Licensing Agreement With Menarini For Spedra 41
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 43
FAES Farma Enters into License Agreement with Menarini For Bilastina 44
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 45
Furiex Pharma Enters Into Licensing Agreement With Menarini Group For Priligy 46
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 48
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 49
Orexo Enters Into Licensing Agreement With Invida Group For Abstral 50
GlaxoSmithKline Enters Into Licensing Agreement With Menarini For Bilastine 51
Acquisition 52
Menarini Group Plans To Acquire Indian Pharma Company 52
Menarini Group Acquires Invida 53
A. Menarini Industrie Farmaceutiche Riunite Srl – Key Competitors 55
A. Menarini Industrie Farmaceutiche Riunite Srl – Key Employees 56
A. Menarini Industrie Farmaceutiche Riunite Srl – Locations And Subsidiaries 57
Head Office 57
Other Locations & Subsidiaries 57
Joint Venture 60
Recent Developments 61
Strategy And Business Planning 61
Mar 13, 2017: Menarini Arrives In Columbia And Peru Two New Offices For A Stronger Connection Between Two Continents 61
Jan 18, 2017: Menarini In Turkey: +25% Growth In 2016 And New Headquarters In Istanbul 62
Corporate Communications 63
Jun 29, 2017: Menarini Increases Number of Members of the Board – for the First Time External Members In Majority 63
Product News 64
Apr 12, 2017: Menarini Brings Sirmione Thermal Water Into Italian Homes 64
03/17/2017: Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia 65
Product Approvals 66
Apr 18, 2016: Selvita files IND Application for its novel, dual PIM/FLT3 inhibitor in AML 66
Other Significant Developments 67
Sep 06, 2016: Menarini Invests In Research And Production In Italy And In Germany It Expands Its Location 67
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Key Facts, 2016 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Deals By Therapy Area, 2011 to YTD 2017 10
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2011 to YTD 2017 12
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Menarini Raunaq Pharma Plans To Acquire Pharma Brands In India For US$80 Million 16
Invida Acquires Dermatology And Primary Care Product Portfolios From Shalaks Pharma For US$20 Million 17
Melinta Therapeutics Enters into Agreement with Menarini 19
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 20
Menarini Asia-Pacific Enters into Agreement with Merck 21
Menarini Forms Joint Venture with BiosYnth 22
Moberg Extends Distribution Agreement with Menarini for Emtrix 23
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 24
Moberg Pharma Extends Distribution Agreement With Menarini 25
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 26
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 27
Menarini Enters Into Agreement With Oxford BioTherapeutics To Develop Antibody-Based Anticancer Drugs 28
Teijin Pharma Extends Co-Marketing Agreement With Menarini For TMX-67 30
Moberg Derma Enters Into Co-Marketing Agreement With Menarini For Emtrix 31
Sinclair Pharma Extends Co-Marketing Agreement With Invida 32
Teijin Pharma Enters Into Co-Marketing Agreement With Menarini Group For TMX-67 33
Invida Group Enters Into Agreement With F. Hoffmann-La Roche 34
Berlin-Chemie Enters into Licensing Agreement with Selvita 36
Berlin-Chemie Enters into Licensing Agreement with Chugai Pharma 37
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 38
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 39
Menarini Enters into Licensing and Development Agreement with 4SC for Resminostat 40
Vivus Enters Into Licensing Agreement With Menarini For Spedra 41
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 43
FAES Farma Enters into License Agreement with Menarini For Bilastina 44
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 45
Furiex Pharma Enters Into Licensing Agreement With Menarini Group For Priligy 46
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 48
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 49
Orexo Enters Into Licensing Agreement With Invida Group For Abstral 50
GlaxoSmithKline Enters Into Licensing Agreement With Menarini For Bilastine 51
Menarini Group Plans To Acquire Indian Pharma Company 52
Menarini Group Acquires Invida 53
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Competitors 55
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Employees 56
A. Menarini Industrie Farmaceutiche Riunite Srl, Subsidiaries 57
A. Menarini Industrie Farmaceutiche Riunite Srl, Joint Venture 60